DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Effect-site Concentration of Remifentanil for Blunting Hemodynamic Responses to Double-lumen Endobronchial Intubation

Information source: Jeju National University School of Medicine
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Intubation, Intratracheal

Intervention: Remifentanil (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Jeju National University School of Medicine

Overall contact:
Hyun Jung Kim, MD, PhD, Phone: 82-64-717-2026, Email: hjanesthesia@empas.com

Summary

The purpose of this study is the comparison of the effect-site concentration of remifentanil for blunting hemodynamic responses to ordinary tracheal and double-lumen endobronchial intubation during propofol-remifentanil total intravenous anesthesia.

Clinical Details

Official title: Comparison of the Effect-site Concentration of Remifentanil for Blunting Hemodynamic Responses to Ordinary Tracheal and Double-lumen Endobronchial Intubation During Propofol-remifentanil Total Intravenous Anesthesia

Study design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Primary outcome: arterial blood pressure

Secondary outcome: heart rate

Eligibility

Minimum age: 18 Years. Maximum age: 60 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Adult patient who is needed intubation for general anesthesia

Exclusion Criteria:

- patient who is anticipating difficult airway

- patient who takes any drug to influence this study

- cardiovascular disease, renal disease, liver disease

Locations and Contacts

Hyun Jung Kim, MD, PhD, Phone: 82-64-717-2026, Email: hjanesthesia@empas.com

Jeju National University Hospital, Jeju-si, Jeju Special Self-Governing Province 690-767, Korea, Republic of; Recruiting
Hyun Jung Kim, MD, PhD, Phone: 82-64-717-2026, Email: hjanesthesia@empas.com
Additional Information

Starting date: October 2013
Last updated: November 27, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017